| Literature DB >> 24966709 |
Agnes Nyabigambo1, Joshua Kanaabi Muliira2, Lynn Atuyambe3, Harriet M Babikako3, Andrew Kambugu4, Christopher Ndoleriire5.
Abstract
There is minimal research that has been conducted among young adults to understand the determinants of the utilization of human immunodeficiency virus (HIV) health services in this population. The purpose of this study was to explore the levels and determinants of HIV transition clinic (HTC) services utilization by young adults living with HIV/acquired immunodeficiency syndrome (YALHA). The study used a cross-sectional design and quantitative methods to collect data from a sample of 379 YALHA between the ages of 15-24 years who were registered clients of an HTC in Uganda. During data analysis, utilization was categorized into two levels: regular (kept all appointment visits) and irregular (missed one or more appointment visits) utilization. Univariable, bivariable, and multivariable logistic regression analyses were used to examine the determinants associated with HTC utilization. The HTC services that were most utilized by the YALHA were those based at the clinic and provided by professional health care providers and these were: clinical examination (96%); laboratory services (87.1%); and counseling (69.7%). The services that were least utilized were home visiting (5.8%) and peer support services (19.8%). Of the 379 YALHA, only 32.4% regularly utilized the HTC. Multivariable analysis showed that the main determinants of HTC utilization were CD4 count category of ≥251/μL (adjusted odds ratio [AOR] =0.58, 95% confidence interval [CI] =0.36-0.95); not being on antiretroviral therapy (AOR =0.27, 95% CI =0.15-0.47); and not receiving counseling services (AOR =0.47, 95% CI =0.27-0.83). Regular utilization of the HTC by YALHA was low and utilization seems to be influenced by HIV infection stage and HIV counseling services, but not sociodemographic factors or community factors.Entities:
Keywords: HIV/AIDS; Uganda; service utilization; transition clinic; young adults
Year: 2014 PMID: 24966709 PMCID: PMC4043429 DOI: 10.2147/AHMT.S57950
Source DB: PubMed Journal: Adolesc Health Med Ther ISSN: 1179-318X
Figure 1Flow diagram showing recruitment of study participants.
Abbreviations: IDI, Infectious Diseases Institute; TC-IDI, Transition Clinic at Infectious Diseases Institute.
Demographic and clinical characteristics of YALHA attending the HTC
| Characteristic | Category | Frequency (N=379) |
|---|---|---|
| Sex | Male | 68 (17.9%) |
| Female | 311 (82.1%) | |
| Age in years (mean =22.5, SD =2.0) | 15–19 years | 41 (10.8%) |
| 20–24 years | 338 (89.2%) | |
| Highest level of education attained | Primary school or below | 142 (37.5%) |
| Secondary school | 176 (46.4%) | |
| Tertiary/university level | 61 (16.1%) | |
| Religion | Catholic | 134 (35.4%) |
| Protestant | 102 (26.9%) | |
| Moslem | 63 (16.6%) | |
| Pentecostal | 80 (21.1%) | |
| Employment status | Employed | 160 (42.2%) |
| Unemployed | 219 (57.8%) | |
| Location of residence | Urban | 245 (64.6%) |
| Rural | 134 (35.4%) | |
| Marital Status | Married | 184 (48.6%) |
| Not married | 195 (51.4%) | |
| Route through which HIV was acquired | 1 do not know | 64 (16.9%) |
| MTCT | 69 (18.2%) | |
| Sexual intercourse | 246 (64.9%) | |
| Ever accessed HIV/AIDs care elsewhere | Yes | 72 (19.0%) |
| No | 307 (81.0%) | |
| Currently on ART (Antiretroviral therapy) | Yes | 231 (61.0%) |
| No | 148 (39.0%) | |
| Last CD4 counts (/μL) (mean =402.3; SD =293.3) | ≤250 | 91 (24.0%) |
| ≥251 | 288 (76.0%) | |
| Word Health Organization (WHO) HIV clinical stage | I | 93 (24.5%) |
| II | 132 (34.8%) | |
| III | 90 (23.8%) | |
| IV | 64 (16.9%) |
Abbreviations: AIDS, acquired immunodeficiency syndrome; ART, antiretroviral therapy; HIV, human immunodeficiency virus; HTC, HIV transition clinic; MTCT, mother-to-child transmission; SD, standard deviation; YALHA, young adults living with HIV/AIDS.
Figure 2Graph showing HTC services utilized by YALHA in the 6 months prior to the study.
Abbreviations: AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus; HTC, HIV transition clinic; YALHA, young adults living with HIV/AIDS.
Relationships between YALHA demographic and clinical characteristics with HTC utilization
| Characteristic | Category | Frequency (N=379) | Regular utilizers frequency (N=123) | Irregular utilizers frequency (N=256) | X2 | cOR | 95% Cl | |
|---|---|---|---|---|---|---|---|---|
| Sex | Male | 68 (17.9%) | 22 (17.9%) | 46 (18.0%) | 0.00 | 0.984 | 1.00 | |
| Female | 311 (82.1%) | 101 (82.1%) | 210 (82.0%) | 1.01 | 0.57–1.76 | |||
| Location of residence | Urban | 245 (64.6%) | 69 (56.1%) | 176 (68.8%) | 5.83 | 0.016 | 1.00 | |
| Rural | 134 (35.4%) | 54 (43.9%) | 80 (31.3%) | 1.72 | 1.11–2.68 | |||
| Age category in years | 15 | 41 (10.8%) | 19 (15.4%) | 22 (8.6%) | 4.04 | 0.044 | 1.00 | |
| 20 | 338 (89.2%) | 104 (84.6%) | 234 (91.4%) | 0.51 | 0.27–0.99 | |||
| Highest level of education attained | Primary school | 142 (37.5%) | 44 (35.8%) | 98 (38.3%) | 0.27 | 0.875 | 1.00 | |
| Secondary school | 176 (46.4%) | 58 (47.2%) | 118 (46.1%) | 1.09 | 0.68–1.76 | |||
| Tertiary/university | 61 (16.1%) | 21 (17.0%) | 40 (15.6%) | 1.17 | 0.62–2.21 | |||
| Religion | Catholic | 134 (35.4%) | 47 (38.2%) | 87 (34.0%) | 3.09 | 0.378 | 1.00 | |
| Protestant | 102 (26.9%) | 26 (21.1%) | 76 (29.7%) | 0.63 | 0.36–1.12 | |||
| Moslem | 63 (16.6%) | 22 (17.9%) | 41 (16.0%) | 0.99 | 0.53–1.86 | |||
| Pentecostal | 80 (121.1%) | 28 (22.8%) | 52 (20.3%) | 1.00 | 0.56–1.78 | |||
| Employment status | Employed | 160 (42.2%) | 47 (38.2%) | 113 (44.1%) | 1.20 | 0.274 | 1.00 | |
| Unemployed | 219 (57.8%) | 76 (61.8%) | 143 (55.9%) | 1.28 | 0.82–1.98 | |||
| Marital status | Married | 184 (48.6%) | 62 (50.4%) | 122 (47.7%) | 0.25 | 0.616 | 1.00 | |
| Not married | 195 (51.4%) | 61 (49.6%) | 134 (52.3%) | 0.90 | 0.58–1.38 | |||
| Route through which HIV was acquired | I do not know | 64 (16.9%) | 19 (15.5%) | 45 (17.6%) | 5.99 | 0.050 | 1.00 | |
| MTCT | 69 (18.2%) | 31 (25.2%) | 38 (14.8%) | 1.93 | 0.94–3.95 | |||
| Sexual intercourse | 246 (64.9%) | 73 (59.3%) | 173 (67.6%) | 1.00 | 0.55–1.82 | |||
| Accessed HIV/AIDS care elsewhere | Yes | 72 (19.0%) | 28 (22.8%) | 44 (17.2%) | 1.68 | 0.195 | 1.00 | |
| No | 307 (81.0%) | 95 (77.2%) | 212 (82.8%) | 0.70 | 0.41–1.20 | |||
| Currently on ART | Yes | 231 (61.0%) | 101 (82.1%) | 130 (50.8%) | 34.27 | 0.000 | 1 00 | |
| No | 148 (39.0%) | 22 (17.9%) | 126 (49.2%) | 0.22 | 0.13–0.38 | |||
| Last CD4 count (/μL) | ≤250 | 91 (24.0%) | 45 (36.6%) | 46 (18.0%) | 15.78 | 0.000 | 1.00 | |
| ≥251 | 288 (76.0%) | 78 (63.4%) | 210 (82.0%) | 0.40 | 0.25–0.62 | |||
| WHO HIV clinical stage | I | 93 (24.5%) | 23 (18.7%) | 70 (27.3%) | 7.81 | 0.050 | 1.00 | |
| II | 132(34.8%) | 38 (30.9%) | 94 (36.7%) | 1.23 | 0.67–2.25 | |||
| III | 90 (23.8%) | 35 (28.4%) | 55 (21.5%) | 1.94 | 1.03–3.65 | |||
| IV | 64 (16.9%) | 27 (22.0%) | 37 (14.5%) | 2.22 | 1.12–4.40 |
Notes:
P-value ≤0.05
P-value ≤0.001
P-value =0.000.
Abbreviations: 95% CI, 95% confidence interval; AIDS, acquired immunodeficiency syndrome; ART, antiretroviral therapy; cOR, crude odds ratio; HIV, human immunodeficiency virus; HTC, HIV transition clinic; MTCT, mother-to-child transmission; WHO, World Health Organization; YALHA, young adults living with HIV/AIDS; CD4, T-helper cells; (χ2), chi-square; N, number; P-value, level of significance.
Community determinants of HTC utilization by YALHA
| Community factor and response | Frequency (N=379) | Regular utilizers frequency (N=123) | Irregular utilizers frequency (N=256) | X2 | cOR | 95% CI | |
|---|---|---|---|---|---|---|---|
| Has a family member to remind about appointments | |||||||
| Yes | 238 (63.0%) | 85 (70.0%) | 153 (60.0%) | 1.00 | |||
| No | 140 (37.0%) | 37 (30.0%) | 103 (40.0%) | 3.48 | 0.062 | 0.65 | 0.41–1.02 |
| Feels rejected because of HIV status | |||||||
| Yes | 76 (20.0%) | 27 (22.0%) | 49 (19.0%) | 1.00 | |||
| No | 303 (80.0%) | 96 (78.0%) | 207 (81.0%) | 0.41 | 0.522 | 0.84 | 0.50–1.43 |
| Disclosed HIV status to another person who is not a HPC | |||||||
| Yes | 354 (93.4%) | 112 (91.1%) | 242 (94.5%) | 1.00 | |||
| No | 25 (6.6%) | 11 (8.9%) | 14 (5.5%) | 1.63 | 0.202 | 1.70 | 0.75–3.86 |
| Has a regular caregiver at home | |||||||
| Yes | 309 (81.5%) | 109 (88.6%) | 200 (78.1%) | 1.00 | |||
| No | 70 (18.5%) | 14 (11.4%) | 56 (21.9%) | 6.07 | 0.014 | 0.46 | 0.24–0.86 |
Note:
P-value ≤0.05.
Abbreviations: 95% CI, 95% confidence interval; AIDS, acquired immunodeficiency syndrome; cOR, crude odds ratio; HIV, human immunodeficiency virus; HPC, health care provider; HTC, HIV transition clinic; YALHA, young adults living with HIV/AIDS; (χ2), chi-square.
Health services delivery factors associated with HTC utilization by YALHA
| Health services delivery determinants | Category | Frequency (N=379) | Regular utilizers frequency (N=123) | Irregular utilizers frequency (N=256) | X2 | cOR | 95% Cl | |
|---|---|---|---|---|---|---|---|---|
| Waiting time during clinic appointments (hours) | 0–1 | 139 (36.7%) | 36 (29.3%) | 103 (40.2%) | 1.00 | |||
| 1–2 | 135 (35.6%) | 47 (38.2%) | 88 (34.4%) | 1.53 | 0.91–2.57 | |||
| >3 | 105 (27.7%) | 40 (32.5%) | 65 (25.4%) | 4.59 | 0.101 | 1.76 | 1.02–3.04 | |
| Rating of the general conduct of the clinic staff | Very good | 234 (61.7%) | 77 (62.6%) | 157 (61.3%) | 1.00 | |||
| Good | 145 (38.3%) | 46 (37.4%) | 99 (38.7%) | 0.06 | 0.81 | 0.95 | 0.61–1.48 | |
| Feels free to express feelings about clinic | Yes | 148 (39%) | 44 (36%) | 104 (40.6%) | 1.00 | |||
| No | 231 (61%) | 79 (64%) | 152 (59.4%) | 0.82 | 0.37 | 1.23 | 0.79–1.92 | |
| Attends health education at the clinic | Yes | 198 (52.2%) | 69 (56.1%) | 129 (50.4%) | 1.00 | |||
| No | 181 (47.8%) | 54 (43.9%) | 127 (49.6%) | 1.08 | 0.30 | 0.79 | 0.52–1.22 | |
| Utilized counseling services | Yes | 264 (69.7%) | 99 (80.5%) | 165 (64.5%) | 1.00 | |||
| No | 115 (30.3%) | 24 (19.5%) | 91 (35.5%) | 10.11 | 0.001 | 0.44 | 0.26–0.74 | |
| Utilized clinical examination services | Yes | 364 (96%) | 123 (100%) | 241 (94.1%) | ||||
| No | 15 (4%) | 0 (0%) | 15 (5.9%) | 7.50 | 0.006 | – | – | |
| Utilized peer support services offered by clinic | Yes | 75 (19.8%) | 29 (23.6%) | 46 (18%) | 1.00 | |||
| No | 304 (80.2%) | 94 (76.4%) | 210 (82%) | 1.65 | 0.199 | 0.71 | 0.42–1.20 | |
| Utilized laboratory services | Yes | 330 (87.1%) | 115 (93.5%) | 215 (84%) | 1.00 | |||
| No | 49 (12.9%) | 8 (6.5%) | 41 (16%) | 6.68 | 0.010 | 0.36 | 0.17–0.80 | |
| Utilized home visiting services of the clinic | Yes | 22 (5.8%) | 5 (4.1%) | 17 (6.6%) | 1.00 | |||
| No | 357 (94.2%) | 118 (95.9%) | 239 (93.4%) | 1.01 | 0.315 | 1.68 | 0.60–4.66 |
Note:
P-value ≤0.05
P-value ≤0.001.
Abbreviations: 95% CI, 95% confidence interval; AIDS, acquired immunodeficiency syndrome; cOR, crude odds ratio; HIV, human immunodeficiency virus; HTC, HIV transition clinic; YALHA, young adults living with HIV/AIDS; (χ2), chi-square.
Determinants of HTC utilization by YALHA
| Factor | Category | cOR | 95% CI | aOR | 95% CI |
|---|---|---|---|---|---|
| CD4 count category(/μL) | ≤250 | 1.00 | 1.00 | ||
| ≥251 | 0.40 | 0.25–0.62 | 0.58 | 0.36–0.95 | |
| Currently on antiretroviral therapy | Yes | 1.00 | 1.00 | ||
| No | 0.22 | 0.13–0.38 | 0.27 | 0.15–0.47 | |
| Received counseling services | Yes | 1.00 | 1.00 | ||
| No | 0.44 | 0.26–0.74 | 0.47 | 0.27–0.83 | |
| Location of place of residence | Urban | 1.00 | 1.00 | ||
| Rural | 1.72 | 1.11–2.68 | 1.59 | 0.98–2.58 | |
| Received laboratory services | Yes | 1.00 | 1.00 | ||
| No | 0.36 | 0.17–0.80 | 0.52 | 0.22–1.22 | |
| HTC waiting time categories during visits in hours | 0–1 | 1.00 | 1.00 | ||
| 1–2 | 1.53 | 0.91–2.57 | 1.25 | 0.71–2.21 | |
| >3 | 1.76 | 1.02–3.04 | 1.44 | 0.80–2.61 | |
| Do you have a regular caregiver at home? | Yes | 1.00 | 1.00 | ||
| No | 0.46 | 0.24–0.86 | 0.67 | 0.34–1.33 | |
| Sex | Male | 1.00 | 1.00 | ||
| Female | 1.01 | 0.57–1.74 | 1.04 | 0.56–1.93 |
Notes:
P-value ≤0.001
P-value =0.000; log-likelihood =−207.10; Pearson l-fit prob > χ2=0.607.
Abbreviations: 95% CI, 95% confidence interval; AIDS, acquired immunodeficiency syndrome; aOR, adjusted odds ratio; cOR, crude odds ratio; HIV, human immunodeficiency virus; HTC, HIV transition clinic; YALHA, young adults living with HIV/AIDS.